These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 12101420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.
    Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, Wang YC.
    Lung Cancer; 2007 Feb; 55(2):205-13. PubMed ID: 17140695
    [Abstract] [Full Text] [Related]

  • 3. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.
    Cancer Res; 2001 Apr 15; 61(8):3419-24. PubMed ID: 11309302
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 15; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.
    Oncogene; 2003 Mar 13; 22(10):1580-8. PubMed ID: 12629521
    [Abstract] [Full Text] [Related]

  • 10. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC.
    Oncogene; 1998 Nov 26; 17(21):2779-85. PubMed ID: 9840942
    [Abstract] [Full Text] [Related]

  • 11. MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells.
    Martin V, Jørgensen HF, Chaubert AS, Berger J, Barr H, Shaw P, Bird A, Chaubert P.
    Pathobiology; 2008 Nov 26; 75(5):281-7. PubMed ID: 18931530
    [Abstract] [Full Text] [Related]

  • 12. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.
    Int J Oncol; 2001 Aug 15; 19(2):277-81. PubMed ID: 11445839
    [Abstract] [Full Text] [Related]

  • 16. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.
    Pathol Int; 2004 Aug 15; 54(8):549-55. PubMed ID: 15260845
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
    Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M, Takahashi T.
    Oncogene; 2002 Apr 04; 21(15):2418-24. PubMed ID: 11948426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J.
    Cancer Res; 2003 Jul 01; 63(13):3743-6. PubMed ID: 12839968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.